Assertio Holdings inc

Officers & Directors

Assertio Holdings inc currently has 53 employees.

News about Assertio Holdings inc Key Personnel

“Assertio Holdings: Navigating Leadership Changes and Clinical Innovations in Oncology After Revenue Challenges”,

Assertio Holdings: Strategic Leadership Changes and Clinical Innovations in Oncology Amid ChallengesAssertio Holdings, Inc. a notable player in the pharmaceutical landscape, is gearing up for a pivotal shift under new leadership while navigating clinical innovations in oncology. The recent appointments of Paul Schwichtenberg as Chief Technology Officer (CTO) and Mary Pietryga as Chief Commercial Officer (CCO) signal Assertio s strategic focus on market expansion and revenue generation. These moves come at a crucial time when the company is also analyzing the economic and clinical implications of its innovative oncology treatment, Rolvedon (eflapegrastim-xnst).Leadership Changes: A Catalyst for GrowthOn Decem...

Business Description

Officers & Directors

ASRT Management Effectiveness

ASRT Revenue per Employee

ASRT Income per Employee

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.